Profile picture

Doctor Mohammed Ahmed Al-Kaif

Fudan University, Shanghai (China)
Follow
Biography
Cardiovascular precision-medicine researcher with a PhD in Pharmaceutical Sciences / Biotechnology and 56 peer-reviewed publications (H-index 28, >21,000 citations). Expert in translating pharmacogenetics and metabolomics into actionable clinical insights for personalized medicine. Awarded Young Investigator Award (ESC Asia) and serving as Young Ambassador for the European Association of Preventive Cardiology (EAPC). Proven track record of securing competitive research funding, leading multi-institutional omics projects, and supervising junior researchers in clinical trial design and multivariate data analysis.
Logo ESC

Contributor content

Platelet reactivity index after treatment of clopidogrel versus ticagrelor based on CYP2C19 genotypes among patients undergoing percutaneous coronary intervention: results of a randomized study
Presentation
Platelet reactivity index after treatment of clopidogrel versus ticagrelor based on CYP2C19 genotypes among patients undergoing percutaneous coronary intervention: results of a randomized study